STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

Large planned and 10b5-1 insider share sales disclosed for CRWV (CRWV)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

This Form 144 notice discloses a planned sale of 1,000 shares of common stock of CRWV through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/02/2026. The shares to be sold were acquired as founders shares from the issuer on 02/25/2019.

The filing also lists extensive Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin J. McBee, related trusts and GRATs, and a non-affiliate donee. Examples include 102835 common shares sold on 01/26/2026 for $10432309.16, and 257733 shares sold on 12/01/2025 for $19592527.61. The person on whose behalf the shares are sold represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does this Form 144 filing for CRWV disclose?

The filing discloses a planned sale of CRWV common stock under Rule 144. It covers a proposed sale of 1000 shares, details their acquisition as founders shares in 2019, identifies the broker and exchange, and itemizes extensive recent Rule 10b5-1 sales by related parties.

How many CRWV shares are planned to be sold under this Form 144 notice?

The notice covers a proposed sale of 1000 CRWV common shares. These shares are described in the securities information table, with an aggregate market value of 93190.00 and a planned sale through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange.

When were the CRWV shares to be sold originally acquired?

The 1000 CRWV shares were acquired on 02/25/2019 as founders shares. The securities-to-be-sold table states they were obtained directly from the issuer on that date, with the nature of the acquisition labeled "Founders Shares" and payment dated the same day as acquisition.

Which broker will handle the planned CRWV share sale disclosed in this Form 144?

The planned CRWV sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the securities are expected to be sold on the NASDAQ exchange.

What Rule 10b5-1 sales of CRWV stock are disclosed for the past three months?

The filing lists numerous Rule 10b5-1 sales of CRWV common stock by Brannin J. McBee, related trusts, GRATs, and a non-affiliate donee. Individual transactions include amounts such as 102835 shares sold on 01/26/2026 and 257733 shares sold on 12/01/2025.

What representation does the selling person make about CRWV in this Form 144?

The selling person represents they do not know any undisclosed material adverse information about CRWV. By signing the notice, they state they lack non-public negative information about the issuer’s current or prospective operations, and similar representation applies if a Rule 10b5-1 plan is being used.